ROCHE HOLDING AG-BR (RHO.DE) Stock Fundamental Analysis
Europe - FRA:RHO - CH0012032113 - Common Stock
305.4 EUR
-12.4 (-3.9%)
Overall RHO gets a fundamental rating of 6 out of 10. We evaluated RHO against 53 industry peers in the Pharmaceuticals industry. While RHO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RHO is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
RHO had positive earnings in the past year.
In the past year RHO had a positive cash flow from operations.
Each year in the past 5 years RHO has been profitable.
Each year in the past 5 years RHO had a positive operating cash flow.
1.2 Ratios
RHO has a Return On Assets of 9.95%. This is in the better half of the industry: RHO outperforms 67.92% of its industry peers.
RHO has a better Return On Equity (32.88%) than 83.02% of its industry peers.
RHO's Return On Invested Capital of 24.24% is amongst the best of the industry. RHO outperforms 86.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RHO is significantly above the industry average of 15.19%.
The 3 year average ROIC (23.72%) for RHO is below the current ROIC(24.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROIC | 24.24% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
1.3 Margins
With a decent Profit Margin value of 15.31%, RHO is doing good in the industry, outperforming 60.38% of the companies in the same industry.
In the last couple of years the Profit Margin of RHO has declined.
Looking at the Operating Margin, with a value of 33.79%, RHO belongs to the top of the industry, outperforming 83.02% of the companies in the same industry.
In the last couple of years the Operating Margin of RHO has remained more or less at the same level.
RHO has a better Gross Margin (73.92%) than 66.04% of its industry peers.
In the last couple of years the Gross Margin of RHO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% |
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RHO is creating value.
Compared to 1 year ago, RHO has less shares outstanding
Compared to 5 years ago, RHO has less shares outstanding
The debt/assets ratio for RHO is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.19 indicates that RHO is not in any danger for bankruptcy at the moment.
RHO has a better Altman-Z score (4.19) than 60.38% of its industry peers.
RHO has a debt to FCF ratio of 2.50. This is a good value and a sign of high solvency as RHO would need 2.50 years to pay back of all of its debts.
RHO's Debt to FCF ratio of 2.50 is fine compared to the rest of the industry. RHO outperforms 69.81% of its industry peers.
RHO has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
RHO has a Debt to Equity ratio of 1.06. This is in the lower half of the industry: RHO underperforms 71.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Altman-Z | 4.19 |
ROIC/WACC5.09
WACC4.76%
2.3 Liquidity
A Current Ratio of 1.29 indicates that RHO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.29, RHO is in line with its industry, outperforming 52.83% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that RHO should not have too much problems paying its short term obligations.
RHO's Quick ratio of 1.02 is fine compared to the rest of the industry. RHO outperforms 64.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.19% over the past year.
The Earnings Per Share has been decreasing by -1.39% on average over the past years.
The Revenue has been growing slightly by 4.77% in the past year.
RHO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.32% yearly.
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
3.2 Future
Based on estimates for the next years, RHO will show a small growth in Earnings Per Share. The EPS will grow by 6.49% on average per year.
RHO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.12% yearly.
EPS Next Y6.05%
EPS Next 2Y5.52%
EPS Next 3Y5.64%
EPS Next 5Y6.49%
Revenue Next Year2.45%
Revenue Next 2Y2.86%
Revenue Next 3Y3.14%
Revenue Next 5Y3.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.36, RHO is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of RHO indicates a somewhat cheap valuation: RHO is cheaper than 66.04% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.83, RHO is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.49, which indicates a correct valuation of RHO.
RHO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. RHO is cheaper than 62.26% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.82, RHO is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.36 | ||
| Fwd PE | 13.49 |
4.2 Price Multiples
RHO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. RHO is cheaper than 62.26% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RHO indicates a somewhat cheap valuation: RHO is cheaper than 66.04% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.31 | ||
| EV/EBITDA | 10.77 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHO does not grow enough to justify the current Price/Earnings ratio.
RHO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.37
PEG (5Y)N/A
EPS Next 2Y5.52%
EPS Next 3Y5.64%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.40%, RHO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.00, RHO pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, RHO pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
5.2 History
The dividend of RHO has a limited annual growth rate of 2.37%.
Dividend Growth(5Y)2.37%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
RHO pays out 85.87% of its income as dividend. This is not a sustainable payout ratio.
The dividend of RHO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP85.87%
EPS Next 2Y5.52%
EPS Next 3Y5.64%
FRA:RHO (10/23/2025, 7:00:00 PM)
305.4
-12.4 (-3.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.11%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap247.14B
Revenue(TTM)61.59B
Net Income(TTM)9.43B
Analysts69.23
Price Target340.2 (11.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
Yearly Dividend10.91
Dividend Growth(5Y)2.37%
DP85.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.33%
PT rev (3m)0.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.12%
EPS NY rev (3m)-4.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-1.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.36 | ||
| Fwd PE | 13.49 | ||
| P/S | 3.71 | ||
| P/FCF | 17.31 | ||
| P/OCF | 11.86 | ||
| P/B | 7.97 | ||
| P/tB | 52.6 | ||
| EV/EBITDA | 10.77 |
EPS(TTM)21.27
EY6.96%
EPS(NY)22.63
Fwd EY7.41%
FCF(TTM)17.64
FCFY5.78%
OCF(TTM)25.76
OCFY8.43%
SpS82.29
BVpS38.32
TBVpS5.81
PEG (NY)2.37
PEG (5Y)N/A
Graham Number135.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.95% | ||
| ROE | 32.88% | ||
| ROCE | 30.98% | ||
| ROIC | 24.24% | ||
| ROICexc | 24.24% | ||
| ROICexgc | 36.85% | ||
| OM | 33.79% | ||
| PM (TTM) | 15.31% | ||
| GM | 73.92% | ||
| FCFM | 21.43% |
ROA(3y)11.64%
ROA(5y)13.32%
ROE(3y)36.55%
ROE(5y)41.17%
ROIC(3y)23.72%
ROIC(5y)23.71%
ROICexc(3y)28.94%
ROICexc(5y)29.11%
ROICexgc(3y)49.53%
ROICexgc(5y)49.86%
ROCE(3y)29.26%
ROCE(5y)30.68%
ROICexgc growth 3Y2.54%
ROICexgc growth 5Y-3.21%
ROICexc growth 3Y1.27%
ROICexc growth 5Y-3.5%
OM growth 3Y4.01%
OM growth 5Y0.18%
PM growth 3Y-14.88%
PM growth 5Y-9.03%
GM growth 3Y2.22%
GM growth 5Y0.6%
F-Score8
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.06 | ||
| Debt/FCF | 2.5 | ||
| Debt/EBITDA | 1.27 | ||
| Cap/Depr | 195% | ||
| Cap/Sales | 9.87% | ||
| Interest Coverage | 17.17 | ||
| Cash Conversion | 80.58% | ||
| Profit Quality | 140.01% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.02 | ||
| Altman-Z | 4.19 |
F-Score8
WACC4.76%
ROIC/WACC5.09
Cap/Depr(3y)132.99%
Cap/Depr(5y)129.62%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.42%
Profit Quality(3y)129.49%
Profit Quality(5y)117.9%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y-1.73%
EPS 5Y-1.39%
EPS Q2Q%8.5%
EPS Next Y6.05%
EPS Next 2Y5.52%
EPS Next 3Y5.64%
EPS Next 5Y6.49%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y-1.24%
Revenue growth 5Y-0.32%
Sales Q2Q%3.67%
Revenue Next Year2.45%
Revenue Next 2Y2.86%
Revenue Next 3Y3.14%
Revenue Next 5Y3.12%
EBIT growth 1Y10.03%
EBIT growth 3Y2.72%
EBIT growth 5Y-0.14%
EBIT Next Year25.3%
EBIT Next 3Y10.44%
EBIT Next 5Y9.17%
FCF growth 1Y12.91%
FCF growth 3Y-2.8%
FCF growth 5Y-2.91%
OCF growth 1Y19.07%
OCF growth 3Y-1.42%
OCF growth 5Y-2.14%
ROCHE HOLDING AG-BR / RHO.DE FAQ
Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?
ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE.
Can you provide the valuation status for ROCHE HOLDING AG-BR?
ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.
How profitable is ROCHE HOLDING AG-BR (RHO.DE) stock?
ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 8 / 10.
What is the expected EPS growth for ROCHE HOLDING AG-BR (RHO.DE) stock?
The Earnings per Share (EPS) of ROCHE HOLDING AG-BR (RHO.DE) is expected to grow by 6.05% in the next year.
How sustainable is the dividend of ROCHE HOLDING AG-BR (RHO.DE) stock?
The dividend rating of ROCHE HOLDING AG-BR (RHO.DE) is 4 / 10 and the dividend payout ratio is 85.87%.